Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer

European Journal of Gynaecological Oncology

Volumn 21, Issue 6, 2000, Pages 599-602

  Topuz, E ^a   Aydiner, A ^a   Saip, P ^a   Eralp, Y ^a   Tas F ^a   Salihoglu Y ^a   Tenekeci, N ^a  

^a NONE   (Turkey)

Author keywords

CA 125; Computerized tomography; Correlation; Intraperitoneal chemotherapy; Laparatomy; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; CISPLATIN; PACLITAXEL;

ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORRELATION FUNCTION; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; OVARY CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-125 ANTIGEN; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; HUMANS; INFUSIONS, PARENTERAL; LAPAROTOMY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034469973     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. The role of surgery in the management of ovarian cancer: Primary and interval cytoreductive surgery
2. Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factors
3. Comparison of CA125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer
4. Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI
5. Transvaginal sonography, colorflow imaging, computed tomographic scanning, and CA125 as a routine follow-up examination in women with pelvic tumor: Detection of recurrent disease
6. Local and systemic complications associated with intraperitoneal chemotherapy
7. Catheter complications associated with intraperitoneal chemotherapy
8. Prognostic factors in advanced ovarian cancer
9. The impact of aggressive debulking surgery and cisplatin based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma
10. Role of CA125 as tumor marker in ovarian carcinoma
11. The CA125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
12. Serum CA125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
13. CA125 levels correlated with second-look operations among ovarian cancer patients
14. Role of CA125 and abdominal pelvic computerized axial tomogram in the monitoring of chemotherapy treatment of ovarian cancer
15. CA125 in gynecological pathology-a review
16. Predictive values of CA125 antigen levels and CT scan in second-look procedures for ovarian cancer
17. CA125 in gynecological malignancies
18. CA125 in the follow-up of patients with ovarian cancer
19. Computed tomography in evaluation of patients with ovarian cancer in complete clinical remission
20. Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: Correlation with second-look laparotomy
21. Can computed tomography substitute for second-look operation in ovarian carcinoma?
22. Computed tomography prior to second-look operation in advanced ovarian cancer
23. Abdominopelvic computed tomography: Evaluation in patients undergoing second-look laparotomy for ovarian carcinoma
24. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer
25. Measurement of the ovarian cancer-associated antigen CA125 in monitoring tumor burden and response to chemotherapy
26. CT prior to second-look operation in ovarian cancer
27. Computed tomography and second-look surgery in ovarian cancer patients
28. Common epithelial cancer of the ovary
29. Second-look laparotomy in ovarian cancer: Evaluation of pathologic variables